Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
PIMCO PDI Stock Builds Base Breakout Watch 20260415 IPHA Innate Pharma SA ADS climbs 368 percent despite sharp Q1 2026 EPS and revenue misses versus analyst estimates Clarivate CLVT Stock Is It Worth Opening a Position Q4 2025 EPS Exceeds Expectations Planet PLAG Stock Dutch Auction 022 20260422 General Motors GM China Helium Supply Crunch Geopolitical Spillovers and Downstream Industry Risks XEL Xcel Energy posts 91 percent YoY Q4 2025 revenue growth shares dip 094 percent on slight EPS miss X Commits to Faster Action on Hate and Terror Content Following UK Ofcom Scrutiny PeapackGladstone PGC Slides 108 as Selling Pressure Mounts 20260515 Veris Residential VRE Q4 2025 Earnings EPS 003 Beats Estimates Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks Intel CEO Signals Foundry Turnaround Gaining Traction as Customer Engagement Rises ViaSat VSAT Rallies 115 as Bulls Target 7381 20260518 As AI Reshapes the Economy Demand Surges for BlueCollar Skilled Workers Infrastructure Control as the Next Frontier for Financial Returns Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Dating Startups Target Fake Profiles as User Frustration Drives Demand for Verified Platforms The Economic Reality of Theatre Dreams Balancing Passion with Financial Prudence Upstart and LendingClub Weighing the Two AIPowered Lending Platforms in 2026 Textron TXT Q1 2026 Earnings EPS Surpasses Estimates by 101 Revenue Details Unavailable ZipRecruiter ZIP Q1 2026 Earnings EPS Beat Expectations Despite Net Loss HeartSciences Inc HSCS Q1 2026 Earnings WiderThanExpected Loss Narrows on Strong Cost Control Shares Rally Interlink Electronics Q3 2025 Earnings NarrowerThanExpected Loss Drives Modest Stock Gain NRXS Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence BRCC Earnings Overview 20260528 Aclaris Therapeutics ACRS Edges Higher Testing Key Resistance Near 481 Kyverna Therapeutics KYTX Faces Resistance at 889 After Pulling Back to 847 Nuveen Dynamic Municipal Opportunities Fund NDMO Creeps Higher Consolidating in a Narrow Range Solventum SOLV Holds Near Support as Momentum Fades Key Levels Tested Infosys INFY Gains 199 as Support Holds Approaching Key Resistance